Electronic Moxibustion Timed by Traditional Theory for Constipation After Stroke
Tests electronic moxibustion, alone or with ear points, for constipation after stroke.
Plain-language title generated from the registry record
Registry title: A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients
Key facts
- Where
- Jinhua, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 80 years old?
Source: NCT07372326, who can take part
Where in China
- 4th Affiliated Hospital, School of Medicine, Zhejiang UniversityJinhua, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Trial code
- NCT07372326
- Record updated
- 28 January 2026
- Original description
This study aims to explore the application effect of Ziwu Liuzhu electronic moxibustion combined with auricular points on constipation in stroke patients through clinical controlled trials, as well as the advantages over using electronic moxibustion alone.Read full original descriptionShow less
A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients
This study aims to explore the application effect of Ziwu Liuzhu electronic moxibustion combined with auricular points on constipation in stroke patients through clinical controlled trials, as well as the advantages over using electronic moxibustion alone.
Inclusion: Meets the diagnostic criteria of both Western medicine and traditional Chinese medicine, and has not undergone surgery or other internal medical treatments, with the occurrence of constipation; The condition is stable, without severe clinical complications; Can accept moxibustion treatment, and the local skin is undamaged; Those who agree to participate in this study and sign the informed consent form.
Exclusion: Patients who have not received the prescribed treatment and whose therapeutic effect cannot be determined; Digestive tract disorders, such as intestinal polyps, tuberculosis, and tumors. Irritable bowel syndrome or constipation secondary to organic diseases (such as endocrine, metabolic or post-operative diseases); abdominal aneurysm, hepatosplenomegaly, or severe cardiovascular, liver, kidney or mental disorders and coagulation disorders; The patient had constipation before the stroke; The patient withdrew from the study due to other reasons during the course of the study; Dropout criteria and termination criteria:; Patients who experience serious adverse events or complications and are not suitable to continue the treatment and thus the trial is terminated; Patients with poor compliance, who withdraw from the treatment during the course of the trial, or who use treatment methods prohibited by this protocol concurrently, or who change the treatment method halfway on their own; Note: For any patient meeting any of the above criteria 1, they will be handled as a dropout case.